Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Diffusion Pharmaceuticals Inc (DFFN)

Diffusion Pharmaceuticals Inc (DFFN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,977
  • Shares Outstanding, K 2,040
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,590 K
  • 60-Month Beta 1.78
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.63
Trade DFFN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.41
  • Most Recent Earnings $-1.04 on 08/08/23
  • Next Earnings Date 08/10/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.95 +48.95%
on 07/17/23
5.19 -15.22%
on 08/16/23
+1.39 (+46.18%)
since 07/14/23
3-Month
2.76 +59.42%
on 07/07/23
5.19 -15.22%
on 08/16/23
+0.56 (+14.59%)
since 05/16/23
52-Week
2.76 +59.42%
on 07/07/23
7.40 -40.54%
on 08/17/22
-2.50 (-36.23%)
since 08/16/22

Most Recent Stories

More News
IMPORTANT ALERT: Halper Sadeh LLC Investigates CFMS, DFFN, ARNC, GRNA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CFMS : 2.26 (unch)
DFFN : 6.60 (+11.68%)
ARNC : 29.99 (+0.03%)
GRNA : 0.2995 (-0.03%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, RADI, BGRY, DFFN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FOCS : 52.99 (-0.02%)
RADI : 15.00 (+0.20%)
BGRY : 1.4000 (-0.71%)
DFFN : 6.60 (+11.68%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, LSI, EXR, DFFN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

HSKA : 119.99 (+0.04%)
LSI : 133.10 (-0.76%)
EXR : 154.77 (+2.30%)
DFFN : 6.60 (+11.68%)
DIFFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Diffusion Pharmaceuticals Inc. - DFFN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Diffusion Pharmaceuticals Inc. (the “Company”)...

DFFN : 6.60 (+11.68%)
Moore Kuehn Encourages DFFN, KMF, CSTI, and BGRY Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

DFFN : 6.60 (+11.68%)
KMF : 6.72 (+0.22%)
KBAL : 12.30 (-0.89%)
BGRY : 1.4000 (-0.71%)
DFFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Diffusion Pharmaceuticals Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) and EIP Pharma Inc. is fair to Diffusion shareholders.

DFFN : 6.60 (+11.68%)
Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation

Diffusion aligns with FDA on design of an open-label, dose-escalation, Phase 2 safety and efficacy study of trans sodium crocetinate (“TSC”) in newly...

DFFN : 6.60 (+11.68%)
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial

Positive effects on oxygenation observed with the 2.5 mg/kg dose at the end of the exercise intervalPositive effects on post-exercise recovery based when...

DFFN : 6.60 (+11.68%)
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer

Appointment brings 20 years of regulatory affairs experience and exceptional leadership capabilities...

DFFN : 6.60 (+11.68%)
Diffusion Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference

CHARLOTTESVILLE, Va., May 17, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical...

DFFN : 6.60 (+11.68%)

Business Summary

Diffusion Pharmaceuticals Inc. is a biotechnology company. Its product pipeline includes Trans Sodium Crocetinate, Glioblastoma Program, Pancreatic Cancer Program and Brain Metastases Program. The Company is focused on cancer treatments, such as radiation therapy and chemotherapy in treatment-resistant...

See More

Key Turning Points

3rd Resistance Point 6.03
2nd Resistance Point 5.61
1st Resistance Point 5.01
Last Price 6.60
1st Support Level 3.98
2nd Support Level 3.56
3rd Support Level 2.95

See More

52-Week High 7.40
Last Price 6.60
Fibonacci 61.8% 5.63
Fibonacci 50% 5.08
Fibonacci 38.2% 4.53
52-Week Low 2.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar